ArticlebioRxiv : the preprint server for biology2025
DeviceAgent: An autonomous multimodal AI agent for flexible bioelectronics.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
The development of flexible bioelectronics remains a complex, multidisciplinary process that demands specialized expertise and labor-intensive efforts, limiting scalability, adaptability and accessibility. Here, we introduce DeviceAgent, an autonomous multimodal AI agent that integrates large language models (LLMs), vision-language models (VLMs), and domain-specific computational tools into a unified framework for bioelectronics research. Leveraging the emergent reasoning abilities of LLMs and VLMs, DeviceAgent enables zero and few-shot generalization, contextual learning, and flexible task execution across modalities. A multimodal context memory system orchestrates these capabilities, providing end-to-end support across the experimental pipeline-from high-level design objectives to fabrication protocol generation, visual defect inspection, and electrophysiological signal analysis, while maintaining human oversight at critical decision points. We demonstrate its capabilities through the development of stretchable mesh electronics for interfacing with human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs), a representative application involving complex device architectures, heterogeneous material nanofabrication, and electrophysiology analysis. DeviceAgent autonomously (1) generates customized bioelectronic layouts; (2) creates comprehensive fabrication protocols tailored to specific materials and processes; (3) identifies microscopic defects using visual reasoning; and (4) analyzes cardiac electrophysiological recordings in an interpretable manner. By embedding LLMs and VLMs within a structured, tool-augmented architecture, DeviceAgent establishes a scalable and accessible paradigm for AI-scientist collaboration in nanofabrication and bioelectronics research.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.